Expression of complement messenger RNAs and proteins by human oligodendroglial cells (Q48317953)

10 February 2018

title

Expression of complement messenger RNAs and proteins by human oligodendroglial cells (English)

1 reference

10 February 2018

1 reference

1 reference

1 reference

10 February 2018

author name string

Andis Klegeris

series ordinal

1 reference

10 February 2018

John Maguire

series ordinal

1 reference

10 February 2018

Patrick L McGeer

series ordinal

1 reference

10 February 2018

publication date

1 June 2003

1 reference

10 February 2018

published in

Glia

1 reference

10 February 2018

volume

1 reference

10 February 2018

issue

1 reference

10 February 2018

page(s)

417-423

1 reference

10 February 2018

Complement biosynthesis in the central nervous system

cites work

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.10234

7 January 2021

Oligodendrocyte-specific protein (OSP) is a major component of CNS myelin

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.10234

7 January 2021

Immunocytochemical localization of the terminal complement complex in multiple sclerosis.

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.10234

7 January 2021

Isolation and characterization of adult microglial cells and oligodendrocytes derived from postmortem human brain tissue.

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.10234

7 January 2021

New monoclonal antibodies reactive with defined sequential epitopes in human myelin basic protein

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.10234

7 January 2021

Gene expression of oligodendrocyte markers in human amniotic epithelial cells using neural cell-type-specific expression system

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.10234

7 January 2021

Expression of complement messenger RNAs by human endothelial cells

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.10234

7 January 2021

The inflammatory response system of brain: implications for therapy of Alzheimer and other neurodegenerative diseases

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.10234

7 January 2021

Expression of complement in the brain: role in health and disease

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.10234

7 January 2021

Immunopathology of secondary-progressive multiple sclerosis

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.10234

7 January 2021

Developmental expression in central and peripheral nervous system of oligodendrocyte cell surface antigens (O antigens) recognized by monoclonal antibodies.

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.10234

7 January 2021

Complement activated C4d immunoreactive oligodendrocytes delineate small cortical plaques in multiple sclerosis

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.10234

7 January 2021

The expression of complement regulatory proteins by adult human oligodendrocytes

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.10234

7 January 2021

Neuronal expression of mRNAs for complement proteins of the classical pathway in Alzheimer brain

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.10234

7 January 2021

Monoclonal antibodies (O1 to O4) to oligodendrocyte cell surfaces: an immunocytological study in the central nervous system

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.10234

7 January 2021

Neurons express proteins of the classical complement pathway in Alzheimer disease

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.10234

7 January 2021

Endothelial cells cultured from human brain microvessels produce complement proteins factor H, factor B, C1 inhibitor, and C4.

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.10234

7 January 2021

Alzheimer patients and Down patients: cerebral preamyloid deposits differ ultrastructurally and histochemically from the amyloid of senile plaques

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.10234

7 January 2021

Complement and cytokine gene expression in cultured microglial derived from postmortem human brains

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.10234

7 January 2021

Expression of complement C4 and C9 genes by human astrocytes

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.10234

7 January 2021

Molecular and cellular characterization of the membrane attack complex, C5b-9, in Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.10234

7 January 2021

Complement-activated oligodendroglia: a new pathogenic entity identified by immunostaining with antibodies to human complement proteins C3d and C4d.

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.10234

7 January 2021

Human heart generates complement proteins that are upregulated and activated after myocardial infarction

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.10234

7 January 2021

Human neurons generate C-reactive protein and amyloid P: upregulation in Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.10234

7 January 2021

Identifiers

DOI

10.1002/GLIA.10234

1 reference

10 February 2018

1 reference

10 February 2018